ECRI ranks 7 at-home COVID-19 tests for usability

ECRI, a nonprofit organization focused on patient safety and healthcare quality, released the first public ranking of commonly used at-home COVID-19 test kits based on usability. 

Advertisement

Researchers analyzed seven popular COVID-19 rapid tests in the Jan. 10 report based on the System Usability Scale, an evaluation tool that rates products on a scale of 0 to 100, with 100 being the easiest to use. None of the analyzed tests received “excellent” scores, with more than 30 points separating the top and bottom tests.

“Our evaluation shows that some rapid tests are much easier to use than others,”” Marcus Schabacker, MD, PhD, president and CEO of ECRI, said in a news release. “If given options, consumers should choose tests that are the easiest to use, because when a test is difficult for a consumer to use, it may lead to an inaccurate result.”

The tests evaluated and their ratings on the System Usability Scale are as follows:

1. On/Go: Very Good (82.9)

2. CareStart: Very Good (80.8)

3. Flowflex: Very Good (79.5)

4. QuickVue: Good (75.6)

5. BinaxNOW: Good (73.3)

6. InteliSwab: Good (73.3)

7. BD Veritor: Okay (51.8)

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

From fragmentation to operational flow: Solving the healthcare workforce puzzle

Tuesday, August 11
1:00 PM - 2:00 PM CDT

Presenters: Dr. Pat Hunt, QGendaAndrea Daugherty, MHA, CISSP, CHCIO, CDH-E, Arrowhead Regional Medical CenterElizabeth Lindsay-Wood, MBA, CHCIO, CDH-E, Moffitt Cancer CenterDeb Muro, El Camino HealthJohn Tejeda, D.H.A., MLS, MPAS, DFAAPA, LSSBB, FACHE, Vascular and Neuroscience Institute

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.